Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference
Certara NASDAQ: CERT executives outlined the company's strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies' 2026 Global Healthcare Conference, with newly appointed Chief Executive Officer Jon Resnick saying the company is focused on creating clearer growth engines and improving execution.
Certara, Inc. (CERT) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Certara, Inc. (CERT) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Certara, Inc. (CERT) Q1 2026 Earnings Call Transcript
Certara, Inc. (CERT) Q1 2026 Earnings Call Transcript
Certara Q1 Earnings Call Highlights
Certara NASDAQ: CERT reported first-quarter 2026 revenue of $106.9 million, up 1% from the prior-year period, as stronger software performance offset softer services results and the company outlined a strategic reset under Chief Executive Officer Jon Resnick.
Certara, Inc. (CERT) Q1 Earnings Miss Estimates
Certara, Inc. (CERT) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.14 per share a year ago.
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst
Certara Inc. (NASDAQ:CERT) shares are up 2.34% on Wednesday as the company announced it has entered into a definitive agreement to sell its Regulatory and Medical Writing business.
Brown Brothers Harriman & Co. Has $46 Million Holdings in Certara, Inc. $CERT
Brown Brothers Harriman and Co. boosted its holdings in shares of Certara, Inc. (NASDAQ: CERT) by 34.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,764,034 shares of the company's stock after acquiring an additional 972,669 shares during the quarter.
Certara, Inc. $CERT Shares Sold by 2Xideas AG
2Xideas AG trimmed its holdings in shares of Certara, Inc. (NASDAQ: CERT) by 41.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 184,198 shares of the company's stock after selling 130,568 shares during the period. 2Xideas AG owned approximately 0.12% of Certara worth
Alpha Wave Global LP Takes Position in Certara, Inc. $CERT
Alpha Wave Global LP acquired a new position in Certara, Inc. (NASDAQ: CERT) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 504,724 shares of the company's stock, valued at approximately $6,168,000. Certara accounts for approximately 0.6% of Alpha
Certara, Inc. (CERT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Certara, Inc. (CERT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Certara, Inc. (CERT) Presents at Leerink Global Healthcare Conference 2026 Transcript
Certara, Inc. (CERT) Presents at Leerink Global Healthcare Conference 2026 Transcript
Certara, Inc. (CERT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Certara, Inc. (CERT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
